Link between antibodies and schizophrenia may offer hope for a cure in some patients

December 8, 2016 by Chris Mcintyre, Oxford Science Blog, University of Oxford
Link between antibodies and schizophrenia may offer hope for a cure in some patients. Credit: Shutterstock

For the first time specific antibodies have been found to be associated with the onset of schizophrenia. A study published in The Lancet Psychiatry, reveals that certain kinds of antibodies appear in the blood of a significant percentage of people presenting with a first episode of psychosis. These antibodies, including those against the 'NMDA receptor', have previously been shown to cause encephalitis, a life threatening inflammation of the brain. This study now shows for the first time, that these same antibodies are also found in people with early presentations of schizophrenia.

Professor Belinda Lennox from the Department of Psychiatry, University of Oxford and Oxford Health NHS Foundation Trust, who led the study, says: 'We have shown that 8.8% of people with a first episode of psychosis have an antibody in their blood that may be responsible for their illness. The only way to detect these is through doing a blood test, as patients with antibodies do not have different symptoms from other people with psychosis.'

The discovery offers fresh hope in terms of new treatment possibilities for people experiencing psychosis. This is because the rapid identification and removal of the same antibodies associated with encephalitis leads to a dramatic improvement, and often complete a cure from the illness. Professor Lennox and her team have successfully treated a number of patients experiencing psychosis, who have these antibodies, using this pioneering form of immunotherapy.

'It began with a devastating psychotic episode and subsequent issues with my memory, sleep, temperature and emotional control,' says Sarah, a patient of Professor Lennox. 'My mood was in total flux, swinging from hallucinations and insomnia to sleeping all day and getting severely depressed.  It took over a year before the autoimmune side of my illness was picked up on through a fortunate research trial.  Three years following my episode I have finally responded after two infusions of immune drugs. I am regaining nearly all of my previous function. It has been like a miracle cure. It is terrifying to imagine that without the correct treatment my symptoms might never have improved. Psychosis, caused by NMDA antibodies, could have dominated and even claimed my life.'

Professor Lennox adds: 'The next important step for this study is to work out whether removing the antibodies will treat psychosis in the same established way as is now used for encephalitis. To do this the research team are starting a randomised controlled trial of immune treatment in people with psychosis and antibodies, starting in 2017.'

This study, funded by the Medical Research Council, recruited 228 people with psychosis from Early Intervention in Psychosis services from across England, including Oxford Health NHS Foundation Trust. People were tested within the first six weeks of treatment. The study also tested a comparison group of healthy controls. They found NMDAR antibodies as well as other antibodies, in patients with . They did not find any NMDAR antibodies in healthy control subjects. When the patients with antibodies were compared with those patients without antibodies there were no differences in their symptoms or illness course.

Antibodies are produced by the immune system to fight infection and protect the body. Sometimes, however, the antibodies cause more problems than they solve – in so-called auto-immune disorders, such as diabetes, multiple sclerosis and rheumatoid arthritis. Psychosis – which is a term for the symptoms seen in – is where a person may experience hallucinations, delusions and confused and disturbed thoughts.

The story of first-hand experience of NMDAR encephalitis was eloquently described by Susannah Cahalan, the New York Post journalist in her book 'Brain on Fire', which has since been made into a feature film released this year.

Explore further: Antibodies to brain proteins may trigger psychosis

More information: Belinda R Lennox et al. Prevalence and clinical characteristics of serum neuronal cell surface antibodies in first-episode psychosis: a case-control study, The Lancet Psychiatry (2016). DOI: 10.1016/S2215-0366(16)30375-3

Related Stories

Antibodies to brain proteins may trigger psychosis

March 5, 2015
Antibodies defend the body against bacterial, viral, and other invaders. But sometimes the body makes antibodies that attack healthy cells. In these cases, autoimmune disorders develop.

World first study reveals antibodies that may trigger psychosis in children

March 31, 2015
A world first study revealing the presence of two antibodies in a sub-group of children experiencing their first episode of psychosis affirms a longstanding recognition that auto-immune disorders play a significant role in ...

Effects of brain damage from an autoimmune encephalitis similar to those of 'angel dust'

April 26, 2016
A new study in Biological Psychiatry reports structural brain damage from an autoimmune encephalitis that impairs behavior in ways that are somewhat similar to the effects of "angel dust."

'Middle England' faces lowest psychosis risk

October 24, 2016
The risk of developing a psychotic disorder such as schizophrenia is highest for young people, men, ethnic minorities and people living in urban areas and poorer neighbourhoods, finds a new study by UCL and the University ...

Dose-dependent link between cannabis use, psychosis relapse

September 29, 2016
(HealthDay)—Cannabis use may raise the risk of psychosis relapse, according to a study published online Sept. 28 in JAMA Psychiatry.

Isolated psychiatric episodes rare, but possible, in common form of autoimmune encephalitis

July 26, 2013
A small percentage of people diagnosed with a mysterious neurological condition may only experience psychiatric changes - such as delusional thinking, hallucinations, and aggressive behavior - according to a new study by ...

Recommended for you

Even toddlers weigh risks, rewards when making choices

September 21, 2018
Every day, adults conduct cost-benefit analyses in some form for decisions large and small, economic and personal: Bring a lunch or go out? Buy or rent? Remain single or start a family? All are balances of risk and reward.

The connection between alcoholism and depression

September 21, 2018
Alcoholism and depression often go hand-in-hand.

Early warning sign of psychosis detected

September 21, 2018
Brains of people at risk of psychosis exhibit a pattern that can help predict whether they will go on to develop full-fledged schizophrenia, a new Yale-led study shows. The findings could help doctors begin early intervention ...

In depression the brain region for stress control is larger

September 20, 2018
Although depression is one of the leading psychiatric disorders in Germany, its cause remains unclear. A recent study at the Max Planck Institute for Human Cognitive and Brain Sciences (MPI CBS) in Leipzig, Germany, found ...

Quitting junk food produces similar withdrawal-type symptoms as drug addiction

September 20, 2018
If you plan to try and quit junk food, expect to suffer similar withdrawal-type symptoms—at least during the initial week—like addicts experience when they attempt to quit using drugs.

American girls read and write better than boys

September 20, 2018
As early as the fourth grade, girls perform better than boys on standardized tests in reading and writing, and as they get older that achievement gap widens even more, according to research published by the American Psychological ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.